Argenx announced a definitive agreement to acquire Forte Biosciences.
14 reports, 6 independent
Updated Aug 12
Gone quiet
Reached 4 outlets in its first 24 hours
- Reports
- 14
- Developments
- 2
- Repetition
- 86%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Argenx announced a definitive agreement to acquire Forte Biosciences.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Argenx targets acquisition of Forte Biosciences.1 source
Argenx completed the acquisition of Forte Biosciences and expanded its pipeline with a CD122 prospect.1 source
Keep exploring
The entities involved
-
Argenx
company in Ghent, Belgium
Nothing else this week.
Coverage
Newest first; wire copies grouped- prnewswire.com
- yahoo.com
- insidermonkey.com
- cnbc.comStocks making the biggest moves premarket: Micron Technology, Forte Biosciences, ExxonMobil, Baker Hughes & more
- manilatimes.netargenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
- biopharmadive.com
- biopharmadive.com
- biopharmadive.com